Wu Zeyong, Huang Haiyan, Shi Yucang, Li Jin, Liao Simu, Xu Shuhao, Xian Jiajie, Cai Xiaofen, Zhang Peihua, Wu Zhiyuan
Plastic Surgery, Affiliated Hospital of Guangdong Medical University, Affiliated Hospital of Guangdong Medical University, Plastic Surgery, No.57 South Renmin Road, Xiashan District, Zhanjiang, Guangdong, 524001, CHINA.
Biomed Mater. 2024 Sep 27. doi: 10.1088/1748-605X/ad80ed.
This study investigates the efficacy of the combination of extracellular matrix/stromal vascular fraction gel (ECM/SVF-gel) and vacuum sealing drainage (VSD) on chronic wounds.
From February 2021 to February 2022, 20 patients with chronic wounds were recruited and were divided into experimental and control groups, with 10 patients in each group. Following debridement, we applied various treatments to all cases for 2 weeks. Subsequently, we observed the changes in the wound area and calculated the rate of wound healing. Simultaneously, the wound margin tissues were collected for histological analysis, and the inflammatory cell infiltration within the wound was assessed using HE staining. Masson staining was used to observe the collagen deposition on the wound surface, and CD31 immunohistochemistry was used to count the number of microvessels to evaluate the angiogenesis (Clinical trial registration number: ChiCTR-INR-17013540).
The therapeutic outcomes for all cases included in this study were favorable after a 2-week treatment period, and the wound area was smaller than before. The experimental group exhibited a significantly higher rate of wound healing compared to the control group. In the experimental group as revealed by HE staining, there was a marked reduction in the infiltration of inflammatory cells in the dermis. Masson staining demonstrated that the deposition of collagen fibers in the experimental group was more than the control group. CD31 immunohistochemistry showed an increased number of new blood vessels in the experimental group compared to the control group. Additionally, ECM/SVF-gel extract significantly enhanced the fibroblast proliferation and migration in vitro.
The application of ECM/SVF gel combined with VSD in chronic wounds can accelerate wound healing by reducing inflammatory reaction, increasing collagen fiber deposition, and promoting angiogenesis. Therefore, the combination of ECM/SVF gel and VSD can be used as a simple, safe, and effective therapeutic method for chronic wounds.
本研究探讨细胞外基质/基质血管成分凝胶(ECM/SVF-凝胶)联合负压封闭引流(VSD)治疗慢性伤口的疗效。
2021年2月至2022年2月,招募20例慢性伤口患者,分为实验组和对照组,每组10例。清创后,对所有病例进行2周的不同治疗。随后,观察伤口面积变化并计算伤口愈合率。同时,采集伤口边缘组织进行组织学分析,采用苏木精-伊红(HE)染色评估伤口内炎症细胞浸润情况。采用Masson染色观察伤口表面胶原沉积情况,采用CD31免疫组化计数微血管数量以评估血管生成(临床试验注册号:ChiCTR-INR-17013540)。
本研究纳入的所有病例经2周治疗后疗效良好,伤口面积较前缩小。实验组伤口愈合率明显高于对照组。HE染色显示,实验组真皮内炎症细胞浸润明显减少。Masson染色表明,实验组胶原纤维沉积多于对照组。CD31免疫组化显示,实验组新生血管数量多于对照组。此外,ECM/SVF-凝胶提取物显著增强了体外成纤维细胞的增殖和迁移能力。
ECM/SVF凝胶联合VSD应用于慢性伤口可通过减轻炎症反应、增加胶原纤维沉积和促进血管生成来加速伤口愈合。因此,ECM/SVF凝胶与VSD联合可作为一种简单、安全、有效的慢性伤口治疗方法。